Collagen Peptides Do More Than Beauty: $8.6B Market, 12% CAGR, Boost Muscle & Bone Density (2026)
Title: Collagen Peptides Do More Than Beauty: $8.6B Market, 12% CAGR, Boost Muscle & Bone Density (2026) Abstract (148 words): The global collagen peptides market, valued at $8.6 billion in 2023, is projected to grow at a 12% CAGR through 2026, driven by expanding applications beyond beauty into muscle preservation and bone density enhancement. Clinical studies demonstrate that 10-15g daily of Type I & III hydrolyzed collagen peptides significantly improves bone mineral density (by 3-5% in 12 months) and muscle mass in sarcopenic adults. Leading brands (Vital Proteins, Great Lakes) prioritize grass-fed, bovine hide sourcing with third-party certifications (NSF, GMP, Halal). Key technical advantages include high bioavailability (low molecular weight 2-5 kDa) versus native collagen; disadvantages include potential digestive sensitivity and lower heat stability. Product comparison reveals peptide chain length and solubility as critical parameters. Industry trends show a shift toward multi-collagen blends (Types I, II, III, V, X) for joint, skin, and bone synergy. Factory audits focusing on enzymatic hydrolysis process and heavy metal testing (below 0.1 ppm lead) are essential for quality assurance. Selection criteria emphasize peptide purity (>95%), dissolution rate, and batch-specific amino acid profiling.